US Map / Missouri
State MO

Clinical Trials in Missouri

Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.

Total Trials
296
Recruiting Now
296
← Back to US Map
Top Conditions in Missouri
Multiple Myeloma (8)Advanced Solid Tumor (7)Breast Cancer (7)Obesity (5)Colorectal Cancer (5)Prostate Cancer (5)Asthma (4)Stage IVB Prostate Cancer AJCC v8 (4)Acute Ischemic Stroke (3)Advanced Solid Tumors (3)Neuroblastoma (3)Chronic Lymphocytic Leukemia (3)

Frequently Asked Questions — Clinical Trials in Missouri

How many clinical trials are currently recruiting in Missouri?
ClinicalMetric currently tracks 296 actively recruiting clinical trials with at least one location in Missouri. The total number of registered studies—including active but not currently enrolling trials—is 296. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Missouri?
Missouri hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Advanced Solid Tumor, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Missouri serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Missouri?
To join a clinical trial in Missouri, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Missouri maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Missouri

NCT06685757 Phase 3
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...
Condition
Antibody-mediated Rejection
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Biogen
View Trial →
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
View Trial →
NCT06791837 N/A
Recruiting
Brain Blood Flow and Lactate in Non-obese and Obese Subjects
Condition
Diabetes
Enrollment
24 pts
Location
United States
Sponsor
University of Missouri-Columbi
View Trial →
NCT05509257 EARLY_Phase 1
Recruiting
Naltrexone Neuroimaging in Teens With Eating Disorders
Condition
Eating Disorders
Enrollment
60 pts
Location
United States
Sponsor
Children's Mercy Hospital Kans
View Trial →
NCT03295981 Phase 3
Recruiting
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of ...
Condition
Giant Cell Tumor of Bone
Enrollment
120 pts
Location
United States, Canada, India
Sponsor
St. Louis University
View Trial →
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
View Trial →
NCT07456865 N/A
Recruiting
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial De...
Condition
Urge Urinary Incontinence
Enrollment
256 pts
Location
United States
Sponsor
MedtronicNeuro
View Trial →
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
View Trial →
NCT06894004 N/A
Recruiting
Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
Condition
Hypercholesterolemia and Hyperlipidemia
Enrollment
100 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT04775485 Phase 2
Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With R...
Condition
Low-grade Glioma
Enrollment
141 pts
Location
United States, Australia, Canada
Sponsor
Day One Biopharmaceuticals, In
View Trial →
NCT06496620 Phase 2
Recruiting
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Condition
COPD
Enrollment
171 pts
Location
United States, Australia, Canada
Sponsor
Uniquity One (UNI)
View Trial →
NCT07467993 Phase 2
Recruiting
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Ho...
Condition
Schizophrenia
Enrollment
142 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05327114 Phase 2, Phase 3
Recruiting
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory De...
Condition
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Enrollment
201 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT06973564 Phase 1, Phase 2
Recruiting
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Condition
Advanced Solid Tumors
Enrollment
294 pts
Location
United States
Sponsor
Jacobio Pharmaceuticals Co., L
View Trial →
NCT06134232 Phase 2
Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + ...
Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Enrollment
400 pts
Location
United States
Sponsor
Dendreon
View Trial →
NCT05582785 N/A
Recruiting
Low Field Magnetic Resonance Imaging Assessment With Outpatients
Condition
Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound
Enrollment
500 pts
Location
United States
Sponsor
Children's Mercy Hospital Kans
View Trial →
NCT05533775 Phase 1, Phase 2
Recruiting
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy i...
Condition
Mature B-Cell Non-Hodgkin Lymphoma
Enrollment
65 pts
Location
United States, Australia, Brazil
Sponsor
Hoffmann-La Roche
View Trial →
NCT05281471 Phase 3
Recruiting
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Phy...
Condition
Platinum-resistant Ovarian Cancer
Enrollment
186 pts
Location
United States
Sponsor
Genelux Corporation
View Trial →
NCT05626114 Phase 2
Recruiting
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Acti...
Condition
Geographic Atrophy
Enrollment
60 pts
Location
United States, Israel
Sponsor
Genentech, Inc.
View Trial →
NCT06686771 Phase 3
Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Condition
Non-small Cell Lung Cancer
Enrollment
320 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT07415044 Phase 2
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Condition
Ulcerative Colitis (UC)
Enrollment
1,431 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT05421858 Phase 3
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult P...
Condition
Candidemia
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Basilea Pharmaceutica
View Trial →
NCT06636058 N/A
Recruiting
Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Amon...
Condition
Obesity
Enrollment
440 pts
Location
United States
Sponsor
University of Illinois at Chic
View Trial →
Page 4 of 12 — 296 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology